🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial studies fludarabine phosphate, low-dose total body irra...
Status
Completed
Location
City of Hope Medical Center
Start Date
1999-11
Trial ID
NCT00005799
Treatments Being Tested
OBJECTIVES: I. Assess the effect of immunosuppression with muromonab-CD3, ...
Status
Completed
Location
Mayo Clinic
Start Date
1999-12
Trial ID
NCT00004482
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Herbert Irving Comprehensive Cancer Center
Start Date
1996-05
Trial ID
NCT00008203
RATIONALE: Cyclosporine may improve low blood counts caused by hematologic ...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2002-03
Trial ID
NCT00031980
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Terminated
Location
Rocky Mountain Cancer Centers
Start Date
2001-10
Trial ID
NCT00041288
Following a transplant for hepatitis C cirrhosis, the infection comes back ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2006-01
Trial ID
NCT00260208
Treatments Being Tested
RATIONALE: A peripheral stem cell, bone marrow, or umbilical cord blood tra...
Status
Completed
Location
Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
Start Date
2005-04
Trial ID
NCT00112645
Giving chemotherapy drugs, such as fludarabine and busulfan, before a donor...
Status
Completed
Location
University of California Davis Cancer Center
Start Date
2007-06
Trial ID
NCT00619645
The purpose of this study is to determine the response and toxicity rate of...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2022-01-01
Trial ID
NCT05166967
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of the current t...
Status
Unknown
Location
The Second Xiangya Hospital, Central South University
Start Date
2018-12-01
Trial ID
NCT03791827